Results 91 to 100 of about 96,704 (164)

Genetic Aberrations in Normal Tissues Adjacent to Biliary Tract Cancers. [PDF]

Biomedicines
Kwon CH, Park SH, Lee HJ, Lee JH, Han SY, Park YM, Seo HI, Kim DU, Noh BG.   +8 more
europepmc   +1 more source

Role of Radiation Therapy for Biliary Tract Cancers. [PDF]

Curr Oncol
Chakraborty MA, Kumar R, Ecker BL, In H, Langan RC, Eskander M, Jabbour SK.   +6 more
europepmc   +1 more source

FGFR2-Rearranged Biliary Tract Cancer: Biology, Resistance Mechanisms, and Emerging Therapeutic Strategies. [PDF]

Cancers (Basel)
Xin X, Miao R.
europepmc   +1 more source

Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx). [PDF]

BMC Cancer
Lagenfelt H, Blomstrand H, Gränsmark E, Elander NO.   +3 more
europepmc   +1 more source

Outcomes of Complex Iatrogenic Biliary Tract Injuries: Retrospective Single-Center Experience from Pakistan. [PDF]

Pak J Med Sci
Farid N, Khan MY, Haq IU, Rashid S.
europepmc   +1 more source

Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases. [PDF]

ESMO Gastrointest Oncol
Barsch M, Godbole I, Metzger P, Benzing M, Klaas L, Decker A, Dammer A, Weiß J, Dopfer EP, Gräßel L, Kuehn J, Miething C, Becker H, Lassmann S, Bronsert P, Schultheis AM, Werner M, Boerries M, Duyster J, Thimme R, Hofmann M, Quante M, Bengsch B.   +22 more
europepmc   +1 more source

Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database. [PDF]

Target Oncol
Dreikhausen L, Olkus A, Dill M, Springfeld C, Heumann P, Schulte N, Atanasova K, Ebert MP, Letsch A, Wandmacher AM, Zhan T.   +10 more
europepmc   +1 more source

Checkpoint inhibition in advanced biliary tract cancer: progress, limitations, and the search for biomarker-driven strategies. [PDF]

J Gastrointest Oncol
Giovannetti E, Rocco MA, Agnetti V, Mariyam L, Fasciana TMA, Garajová I.   +5 more
europepmc   +1 more source

PMEPA1 modulates YAP1 nuclear translocation to disrupt EMT subtypes and promote metastasis in Biliary tract cancer. [PDF]

Cell Death Dis
Xu W, Ma C, Li P, Lyu X, Xu R, Sheng K, Zhang T, Sun H, Zhang Z, Wang Z, Li H, Guo D, Huang S.   +12 more
europepmc   +1 more source